Mounjaro (Tirzepatide) Molecule

Mounjaro (Tirzepatide) Molecule


Mounjaro (tirzepatide) is an FDA approved drug created by Lilly for the treatment of diabetes, along with diet and exercise (SURPASS clinical trials). Mounjaro is a single molecule that activates the body’s incretin hormones GIP and GLP1. Incretin hormones are hormones that tell your pancreas to release stored insulin when you eat a meal. 

Glp-1 (Glucagon Like Peptide)

  • Single molecule made in the small intestine and colon
  • Causes the pancreas to make insulin when sugar is in the blood stream, in a dose dependent fashion (the more sugar you have, the more GLP-1 tells the pancreas to release insulin)
  • Tells the gastrointestinal tract to slow down digestion
  • Slows down carbohydrate absorption (so your blood sugar doesn’t escalate quickly)
  • Curbs appetite
  • Animal studies show GLP-1 may promote regeneration of the beta cells in the pancreas by fighting programmed cell death (apoptosis). 

Gip (Glucose Dependent Insulinotropic Polypeptide)

 

  • Single molecule made in the upper intestinal cells
  • Released by the intestinal cell when glucose (sugar) collides with it
  • Causes the pancreas’s beta cells to give out insulin
  • Insulin pushes sugar in the blood stream into the cell for energy
  • Sugar moving out of the blood stream into the cell lowers your blood sugar levels (contributor to diabetes) 
  • GIP appears to improve beta cell growth and survival 

 

 

Mounjaro (Tirzepatide) Has Been So Effective In Helping Patients With Diabetes Lower Their Hemoglobin A1c And Obese Patients Lose Weight (Upwards Of 22% Body Mass Loss Over 72 Weeks) That Lilly Is Seeking Fda Approval For Tirzepatide As A Weight Loss Drug

Are You Diabetic Or Need Help Losing Weight? Are You Frustrated With Your Efforts So Far And Need Renewed Hope? Do You Experience:

  • water retention
  • aches and pains all over from inflammation
  • fatigue
  • constant hunger or food talk
  • high blood pressure
  • high cholesterol
  • nonalcoholic fatty liver
  • obesity

What Does This Look Like For You?

  • If you are a diabetic and your HgbA1C is 9.4% (average blood sugar of 223), taking 15mg of Mounjaro (tirzepatide) once a week could lower your HgbA1C could be 7% (average glucose of 154).
  • If you weigh 199 pounds, you could lower your weight to 176 pounds.

Connect With Us To See If Mounjaro (Tirzepatide) Is Right For You.

Your Options:

 

We Will Send You A Questionnaire To Determine If This Medication Is Right For You.

 

< Older Post

Newer Post >